593 related articles for article (PubMed ID: 17581412)
1. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
2. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
3. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR
Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
[TBL] [Abstract][Full Text] [Related]
4. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis.
Mittal KR; Barwick KW
Gynecol Oncol; 1993 May; 49(2):197-201. PubMed ID: 8504988
[TBL] [Abstract][Full Text] [Related]
5. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
6. The significance of tumor involved adenomyosis in otherwise low-stage endometrioid adenocarcinoma.
Hanley KZ; Dustin SM; Stoler MH; Atkins KA
Int J Gynecol Pathol; 2010 Sep; 29(5):445-51. PubMed ID: 20736770
[TBL] [Abstract][Full Text] [Related]
7. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma.
Ali A; Black D; Soslow RA
Int J Gynecol Pathol; 2007 Apr; 26(2):115-23. PubMed ID: 17413976
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
[TBL] [Abstract][Full Text] [Related]
9. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
Srodon M; Klein WM; Kurman RJ
Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582
[TBL] [Abstract][Full Text] [Related]
10. Endometrial endometrioid adenocarcinoma: a pathologic analysis of 827 consecutive cases.
Nofech-Mozes S; Ghorab Z; Ismiil N; Ackerman I; Thomas G; Barbera L; Covens A; Khalifa MA
Am J Clin Pathol; 2008 Jan; 129(1):110-4. PubMed ID: 18089496
[TBL] [Abstract][Full Text] [Related]
11. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
[TBL] [Abstract][Full Text] [Related]
12. Endometrial carcinoma in adenomyosis: assessment of myometrial invasion on T2-weighted spin-echo and gadolinium-enhanced T1-weighted images.
Utsunomiya D; Notsute S; Hayashida Y; Lwakatare F; Katabuchi H; Okamura H; Awai K; Yamashita Y
AJR Am J Roentgenol; 2004 Feb; 182(2):399-404. PubMed ID: 14736670
[TBL] [Abstract][Full Text] [Related]
13. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.
Quick CM; May T; Horowitz NS; Nucci MR
Int J Gynecol Pathol; 2012 Jul; 31(4):337-43. PubMed ID: 22653347
[TBL] [Abstract][Full Text] [Related]
14. Predictors of final histology in patients with endometrial cancer.
Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC
Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947
[TBL] [Abstract][Full Text] [Related]
15. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
[TBL] [Abstract][Full Text] [Related]
16. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.
Gadducci A; Cavazzana A; Cosio S; DI Cristofano C; Tana R; Fanucchi A; Teti G; Cristofani R; Genazzani AR
Anticancer Res; 2009 May; 29(5):1715-20. PubMed ID: 19443392
[TBL] [Abstract][Full Text] [Related]
17. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: a clinicopathologic study of 23 cases.
Jacques SM; Lawrence WD
Gynecol Oncol; 1990 Jun; 37(3):401-7. PubMed ID: 2351325
[TBL] [Abstract][Full Text] [Related]
18. Reliability of magnetic resonance imaging in assessing myometrial invasion absence in endometrial carcinoma.
Suh DS; Kim JK; Kim KR; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Acta Obstet Gynecol Scand; 2009; 88(9):990-3. PubMed ID: 19636979
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative gross assessment of myometrial invasion and cervical involvement in endometrial cancer: Role of tumor grade and size.
Fotiou S; Vlahos N; Kondi-Pafiti A; Zarganis P; Papakonstantinou K; Creatsas G
Gynecol Oncol; 2009 Mar; 112(3):517-20. PubMed ID: 19117598
[TBL] [Abstract][Full Text] [Related]
20. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
Stokes GN; Shelton JB; Zahn CM; Kendall BS
Gynecol Oncol; 2002 Jan; 84(1):58-61. PubMed ID: 11748977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
